Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| KVUE | Kenvue Inc. | 2026-03-03 12:11:00 | 18.18 | -0.7 | -3.73 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KVUE | 0001944048 | Kenvue Inc. | US49177J1025 | 5493008HSF8L4M2LIJ82 | 881032011 | NYSE | 2844 | Perfumes, Cosmetics & Other Toilet Preparations | 1228 | DE | 1 KENVUE WAY | SUMMIT | NJ | 07901 | UNITED STATES | US | 908-874-1200 | 1 KENVUE WAY, SUMMIT, NJ, 07901 | 1 KENVUE WAY, SUMMIT, NJ, 07901 | JNTL, Inc. | Consumer products | 2022-02-23 | Kirk Perry | 22,000 | http://kenvue.com | 39,600,000,000 | 1,936,502,167 | 1,916,732,090 | Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey. | 2026-02-26 15:33:36 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 39,600,000,000 | 4,800,000,000 | 13.7931 | 1,916,732,090 | 5,491,370 | 0.2873 |
| 2024 | 34,800,000,000 | 29,500,000,000 | 556.6038 | 1,911,240,720 | -3,341,131 | -0.1745 |
| 2023 | 5,300,000,000 | 5,300,000,000 | 100 | 1,914,581,851 | 1,914,581,851 | 100 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Carlton Lawson | Group President | 2024 | 664,260 | 750,000 | 1,405,976 | 516,346 | 369,652 | 4,495,231 |
| Ellie Bing Xie | Group President | 2024 | 595,000 | 750,000 | 1,168,717 | 189,403 | 1,099,472 | 4,311,317 |
| Thibaut Mongon | Chief Executive Officer | 2024 | 1,250,000 | 1,500,000 | 6,246,004 | 1,136,875 | 316,343 | 13,167,969 |
| Paul Ruh | Chief Financial Officer | 2024 | 750,000 | 1,000,000 | 1,405,976 | 393,375 | 142,235 | 4,303,583 |
| Meredith Stevens | Chief Operations Officer | 2024 | 595,000 | 750,000 | 1,168,717 | 371,473 | 112,641 | 3,506,556 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 22,000 |
| 2024 | 22,000 |
| 2023 | 22,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 15,124,000,000 | 15,455,000,000 | 15,444,000,000 |
| Cost Of Revenue | 6,332,000,000 | 6,496,000,000 | 6,801,000,000 |
| Gross Profit | 8,792,000,000 | 8,959,000,000 | 8,643,000,000 |
| Research And Development Expenses | 382,000,000 | 408,000,000 | 399,000,000 |
| General And Administrative Expenses | 6,088,000,000 | 6,329,000,000 | 6,141,000,000 |
| Operating Expenses | — | — | — |
| Operating Income | 2,414,000,000 | 1,841,000,000 | 2,512,000,000 |
| Net Income | 1,470,000,000 | 1,030,000,000 | 1,664,000,000 |
| Earnings Per Share Basic | 0.77 | 0.54 | 0.9 |
| Earnings Per Share Diluted | 0.76 | 0.54 | 0.9 |
| Weighted Average Shares Outstanding Basic | 1,917,000,000 | 1,915,000,000 | 1,846,135,000 |
| Weighted Average Shares Outstanding Diluted | 1,924,000,000 | 1,923,000,000 | 1,850,325,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 1,062,000,000 | 1,070,000,000 | 1,382,000,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 2,382,000,000 | 2,165,000,000 | 2,073,000,000 |
| Inventories | 1,666,000,000 | 1,591,000,000 | 1,851,000,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 155,000,000 | 205,000,000 | 265,000,000 |
| Total Assets Current | 5,697,000,000 | 5,525,000,000 | 6,138,000,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 2,212,000,000 | 1,849,000,000 | 2,042,000,000 |
| Other Assets Non Current | 727,000,000 | 726,000,000 | 623,000,000 |
| Total Assets Non Current | 2,212,000,000 | 1,849,000,000 | 2,042,000,000 |
| Total Assets | 27,076,000,000 | 25,601,000,000 | 27,851,000,000 |
| Accounts Payable | 2,473,000,000 | 2,254,000,000 | 2,489,000,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 1,453,000,000 | 1,552,000,000 | 599,000,000 |
| Other Liabilities Current | 1,159,000,000 | 1,132,000,000 | 1,456,000,000 |
| Total Liabilities Current | 5,945,000,000 | 5,739,000,000 | 5,481,000,000 |
| Long Term Debt | — | — | 7,687,000,000 |
| Other Liabilities Non Current | 601,000,000 | 536,000,000 | 491,000,000 |
| Total Liabilities Non Current | 10,366,000,000 | 10,194,000,000 | 11,159,000,000 |
| Total Liabilities | 16,311,000,000 | 15,933,000,000 | 16,640,000,000 |
| Common Stock | 19,000,000 | 19,000,000 | 19,000,000 |
| Retained Earnings | -204,000,000 | -93,000,000 | 429,000,000 |
| Accumulated Other Comprehensive Income | -4,959,000,000 | -6,146,000,000 | -5,377,000,000 |
| Total Shareholders Equity | 10,765,000,000 | 9,668,000,000 | 11,211,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 557,000,000 | 622,000,000 | 322,000,000 |
| Share Based Compensation Expense | 136,000,000 | 254,000,000 | 188,000,000 |
| Other Non Cash Income Expense | -67,000,000 | -69,000,000 | -6,000,000 |
| Change In Accounts Receivable | 112,000,000 | 218,000,000 | -44,000,000 |
| Change In Inventories | 12,000,000 | -182,000,000 | -349,000,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -122,000,000 | 17,000,000 | 429,000,000 |
| Change In Accounts Payable | 41,000,000 | -536,000,000 | 390,000,000 |
| Change In Other Liabilities | -3,000,000 | 52,000,000 | -212,000,000 |
| Cash From Operating Activities | 2,197,000,000 | 1,769,000,000 | 3,168,000,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 475,000,000 | 434,000,000 | 469,000,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | -15,000,000 | -15,000,000 | 40,000,000 |
| Cash From Investing Activities | -436,000,000 | -425,000,000 | -488,000,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 1,581,000,000 | 1,552,000,000 | 766,000,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 197,000,000 | 235,000,000 | — |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | 91,000,000 | 63,000,000 | -186,000,000 |
| Cash From Financing Activities | -1,837,000,000 | -1,565,000,000 | -2,527,000,000 |
| Change In Cash | -8,000,000 | -312,000,000 | 151,000,000 |
| Cash At End Of Period | 1,062,000,000 | 1,070,000,000 | 1,382,000,000 |
| Income Taxes Paid | 595,000,000 | 810,000,000 | 699,000,000 |
| Interest Paid | 440,000,000 | 439,000,000 | 224,000,000 |
| Fiscal Year | 2025 | 2024 |
|---|---|---|
| Earnings Per Share | 0.77 | 0.54 |
| Price To Earnings Ratio | 22.3247 | 39.2222 |
| Earnings Growth Rate | 42.5926 | -40 |
| Price Earnings To Growth Ratio | 0.5241 | -0.9806 |
| Book Value Per Share | 5.6155 | 5.0486 |
| Price To Book Ratio | 3.0611 | 4.1953 |
| Ebitda | 3,052,000,000 | 2,893,000,000 |
| Enterprise Value | — | — |
| Dividend Yield | 0.048 | 0.0383 |
| Dividend Payout Ratio | 1.0755 | 1.5068 |
| Debt To Equity Ratio | — | — |
| Capital Expenditures | 920,000,000 | 429,000,000 |
| Free Cash Flow | 1,277,000,000 | 1,340,000,000 |
| Return On Equity | 0.1366 | 0.1065 |
| One Year Beta | 0.227 | 0.2721 |
| Three Year Beta | 0.3116 | 0.436 |
| Five Year Beta | 0.3116 | 0.436 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Howlett Heather | VP & Chief Accounting Officer | 2026-02-13 | 12,016 | A | 33,284 |
| Howlett Heather | VP & Chief Accounting Officer | 2026-02-13 | 4,131 | D | 29,153 |
| Howlett Heather | VP & Chief Accounting Officer | 2026-02-13 | 1,555 | A | 30,708 |
| Howlett Heather | VP & Chief Accounting Officer | 2026-02-13 | 518 | D | 30,190 |
| Howlett Heather | VP & Chief Accounting Officer | 2026-02-13 | 12,016 | D | 0 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Sheldon Whitehouse | Senator | 2025-09-03 | Sale (Full) | 2025-08-28 | Spouse | $1,001 - $15,000 |
| Sheldon Whitehouse | Senator | 2024-12-05 | Sale (Full) | 2024-11-18 | Self | $1,001 - $15,000 |
| Sheldon Whitehouse | Senator | 2023-10-17 | Purchase | 2023-09-20 | Self | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Gilbert Cisneros | 2026-02-13 | CA31 | Sale | 2026-01-09 | — | $1,001 - $15,000 |
| Julia Letlow | 2026-01-13 | LA05 | Sale | 2025-10-01 | — | $1,001 - $15,000 |
| Julia Letlow | 2026-01-13 | LA05 | Purchase | 2024-10-23 | — | $1,001 - $15,000 |
| Gilbert Cisneros | 2025-12-15 | CA31 | Purchase | 2025-11-12 | — | $1,001 - $15,000 |
| Lisa McClain | 2025-11-21 | MI09 | Sale | 2025-10-30 | Spouse | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 2025-12-31 | 707 | 41 | 17.2439 |
| Strategic Investment Solutions, Inc. /IL | 2025-12-31 | 5,227 | 303 | 17.2508 |
| Banque Transatlantique SA | 2025-12-31 | 3,481 | 201 | 17.3184 |
| Bell Investment Advisors, Inc | 2025-12-31 | 14,784 | 857 | 17.2509 |
| CHELSEA COUNSEL CO | 2025-12-31 | 307,033 | 17,799 | 17.25 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| AZZAD FUNDS | 2025-12-31 | Azzad Wise Capital Fund | WISEX | 24,469 | 422,090.25 | 0.12 |
| PIMCO Equity Series | 2025-12-31 | PIMCO RAFI ESG U.S. ETF | RAFE | 10,568 | 182,298 | 0.1524 |
| PIMCO Equity Series | 2025-12-31 | PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF | MFUS | 2,499 | 43,107.75 | 0.0205 |
| PIMCO VARIABLE INSURANCE TRUST | 2025-12-31 | Institutional | PVGMAPI | 47,600 | 821,100 | 0.284 |
| PIMCO VARIABLE INSURANCE TRUST | 2025-12-31 | Advisor Class | VPVGMVV | 47,600 | 821,100 | 0.284 |